Showing results (131-140 of 137) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Transplantation and Cellular Therapy|October 9, 2023
Elevation of Urinary Liver-Type Fatty Acid-Binding Protein Is a Harbinger of Poor Patient Prognosis after Allogeneic Stem Cell TransplantationNaoki Shingai, Akihito Ota, Kana Kato, et al.Cancer Science|October 12, 2022
Phase I trial of myeloablative conditioning with 3-day total marrow and lymphoid irradiation for leukemiaHiroaki Ogawa, Tatsuya Konishi, Yuho Najima, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|April 20, 2017
Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial HypertensionNobuhiro Tanabe, Satoshi Ikeda, Nobuhiro Tahara, et al.Leukemia Research|April 30, 2025
Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adultsKaori Kondo, Yuho Najima, Daichi Sadato, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Clinical outcomes of idecabtagene vicleucel therapy for relapsed/refractory multiple myeloma: a single-center retrospective analysis]Kairi Kojo, Yuho Najima, Kyoko Haraguchi, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2024
[FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with PTPN11 mutation at relapse]Kazuya Kurihara, Daichi Sadato, Yuho Najima, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2022
[Tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma: real-world data from single institute experience]Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, et al.Pageof 14